Recombinant Human LIF Rα
- -
- -
BackgroundLeukemia inhibitory factor receptor alpha (LIF Rα), also known as CD118, is a subunit of the receptor for leukemia inhibitory factor LIF, which is a pleiotropic cytokine affecting the differentiation, survival and proliferation of a wide variety of cells in the adult and the embryo (1). LIF action is mediated through a high-affinity heterodimeric receptor complex consisting of two membrane glycoproteins: LIF Rα that binds LIF with low affinity and the gp130 subunit that does not bind LIF by itself, but is required for high-affinity binding of LIF by the complex. The gp130 subunit was first described as the signal transducing subunit of the high-affinity IL-6 receptor complex (2). Signaling for the LIF complex is achieved through activation of the JAK-STAT pathway. The LIF complex also mediates the activities of oncostatin M (OSM) (3), cardiotropin-1 and ciliary neurotrophic factor (CNTF) (4). Soluble LIF Rα has been shown to bind LIF and has LIF antagonistic activities. Defects in LIF Rα are the cause of Stueve-Wiedemann syndrome (SWS), a severe autosomal recessive condition and belongs to the group of the bent-bone dysplasias (5). Protein DetailsPurity >90% by SDS-PAGE and analyzed by silver stain. Endotoxin Level <0.1 EU/µg as determined by the LAL method Protein Accession No. Amino Acid Sequence qkkgap hdlkcvtnnl qvwncswkap sgtgrgtdye vcienrsrsc yqlektsiki palshgdyei tinslhdfgs stskftlneq nvslipdtpe ilnlsadfst stlylkwndr gsvfphrsnv iweikvlrke smelvklvth nttlngkdtl hhwswasdmp lecaihfvei rcyidnlhfs gleewsdwsp vkniswipds qtkvfpqdkv ilvgsditfc cvsqekvlsa lightncpli hldgenvaik irnisvsass gtnvvftted nifgtvifag yppdtpqqln cethdlkeii cswnpgrvta lvgpratsyt lvesfsgkyv rlkraeaptn esyqllfqml pnqeiynftl nahnplgrsq stilvnitek vyphtptsfk vkdinstavk lswhlpgnfa kinflceiei kksnsvqeqr nvtikgvens sylvaldkln pytlytfrir cstetfwkws kwsnkkqhlt teaspskgpd twrewssdgk nliiywkplp ineangkils ynvscssdee tqslseipdp qhkaeirldk ndyiisvvak nsvgssppsk iasmeipndd lkieqvvgmg kgilltwhyd pnmtcdyvik wcnssrsepc lmdwrkvpsn stetviesde frpgirynff lygcrnqgyq llrsmigyie elapivapnf tvedtsadsi lvkwedipve elrgflrgyl fyfgkgerdt skmrvlesgr sdikvknitd isqktlriad lqgktsyhlv lraytdggvg peksmyvvtk ens State of Matter Lyophilized Predicted Molecular Mass The predicted molecular weight of Recombinant Human LIF Rα is Mr 89 kDa. However, the actual molecular weight as observed by migration on SDS-PAGE is Mr 100-110 kDa. Predicted Molecular Mass 89 Formulation This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives. Storage and Stability This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions. Country of Origin USA Shipping Next Day Ambient NCBI Gene Bank References & Citations1. Meng, L. et al.(1995) Nature378:724–727 2. Hilton, DJ. et al.(1988) J. of Biol. Chem. 263: 9238 Certificate of AnalysisIMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein. |
Related Products
Products are for research use only. Not for use in diagnostic or therapeutic procedures.